Invention Grant
US08685370B2 Integrin targeting agents and in-vivo and in-vitro imaging methods using the same
有权
整合素靶向剂和使用其的体内和体外成像方法
- Patent Title: Integrin targeting agents and in-vivo and in-vitro imaging methods using the same
- Patent Title (中): 整合素靶向剂和使用其的体内和体外成像方法
-
Application No.: US12922594Application Date: 2009-03-13
-
Publication No.: US08685370B2Publication Date: 2014-04-01
- Inventor: Milind Rajopadhye , Guojie Ho , Bohumil Bednar , Le T. Duong , Paul J. Coleman
- Applicant: Milind Rajopadhye , Guojie Ho , Bohumil Bednar , Le T. Duong , Paul J. Coleman
- Applicant Address: US MA Bedford US NJ Rahway
- Assignee: Visen Medical, Inc.,Merck & Co., Inc.
- Current Assignee: Visen Medical, Inc.,Merck & Co., Inc.
- Current Assignee Address: US MA Bedford US NJ Rahway
- Agency: Gifford, Krass, Sprinkle, Anderson & Citkowski, P.C.
- International Application: PCT/US2009/037114 WO 20090313
- International Announcement: WO2009/114776 WO 20090917
- Main IPC: A61K49/00
- IPC: A61K49/00
Abstract:
The invention provides a family of agents that target integrins, which can be used as imaging agents and/or therapeutic agents. The agents can be used to image angiogenesis, inflammation or other physiological processes in a subject.
Public/Granted literature
- US20110165075A1 INTEGRIN TARGETING AGENTS AND IN-VIVO AND IN-VITRO IMAGING METHODS USING THE SAME Public/Granted day:2011-07-07
Information query
